Molecular targets associated with ulcerative colitis and the benefits of atractylenolides-based therapy.
Qian H, Ye Z, Hu Y, Wu M, Chen L, Li L, Hu Z, Zhao Q, Zhang C, Yang M, Xudong W, Ye Q, Qin K.
Qian H, et al. Among authors: ye q, ye z.
Front Pharmacol. 2024 May 27;15:1398294. doi: 10.3389/fphar.2024.1398294. eCollection 2024.
Front Pharmacol. 2024.
PMID: 38860174
Free PMC article.
Review.